OTC · Medical - Devices

3-D Matrix, Ltd. (DMTRF) Stock

$2.50 +0.00% OTC: DMTRF Healthcare

3-D Matrix, Ltd. specializes in advancing self-assembling peptide technology.

Valuation

MetricValue
Price$2.50
Market Cap$319.95M
P/E Ratio10.15
P/B Ratio6.38
P/S Ratio3.91
EPS (TTM)$0.25
52-Week High$3.96
52-Week Low$0.69
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE89.26%
ROA42.42%
ROCE19.52%
Gross Margin78.74%
Operating Margin12.27%
Net Margin38.17%
Debt/Equity0.09
Current Ratio3.11

Annual Financials (USD)

Metric20222023202420252026
Revenue$1.5B$2.3B$4.6B$6.9B$10.9B
Operating Profit$-2.7B$-3.2B$-2.1B$-1.2B$1.3B
Net Profit$-1.9B$-2.4B$-256.0M$-2.5B$4.1B
EPS$-37.20$-40.64$-3.49$-25.20$31.28
Op Margin-181.7%-136.5%-46.1%-16.7%12.3%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$5.6B$5.8B$5.9B$6.5B$9.8B
Total Liabilities$4.2B$5.3B$5.5B$4.3B$3.0B
Cash$2.8B$1.2B$1.4B$1.6B$2.8B
Borrowings$3.7B$4.4B$4.2B$2.9B$599.0M

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$-2.9B$-4.6B$-1.9B$-1.7B$396.0M
Investing Cash Flow$-161.0M$-150.0M$-34.0M$-46.0M$-70.0M
Financing Cash Flow$12.0M$1.0M$16.0M$-3.0M$-11.0M
Net Cash Flow$1.7B$-1.7B$193.0M$217.0M$1.1B
Free Cash Flow$-3.0B$-4.7B$-1.9B$-1.7B$368.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA13.57
FCF Yield0.00%
Quick Ratio2.04
Interest Coverage74.13
Return 1Y262.32%
Return 3Y125.23%
Return 5Y—

Ownership

Insiders Held7.41%
Institutions Held7.37%
Institutions Float Held7.96%
Institutional HolderSharesReport Date
Curio Wealth, LLC 38,9002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABTIAlterola Biotech, Inc. $0.00 — -0.11 $291900 0.00%
AONCAmerican Oncology Network, Inc. $12.00 +20.00% -17.39 $350.98M 0.00%
CMVLFCellectis S.A. $3.47 +12.66% -4.24 $251.93M 0.00%
EAPIFEuroapi S.A. $1.51 +0.00% -0.29 $144.31M 0.00%
EDTXFSpectral Medical Inc $0.97 -3.20% -9.89 $284.16M 0.00%

About 3-D Matrix, Ltd.

3-D Matrix, Ltd. specializes in advancing self-assembling peptide technology. The company's primary offering is PuraMatrix, an innovative self-assembling peptide hydrogel utilized across diverse medical sectors such as regenerative medicine, cell-based therapies, sophisticated drug delivery mechanisms, and various surgical applications. This Tokyo, Japan-based entity was founded in 2004.

3-D Matrix, Ltd. is headquartered in JP.

3-D Matrix, Ltd. (DMTRF) stock trades at $2.50 with a market capitalization of $319.95M. The stock is valued at a price-to-earnings (P/E) ratio of 10.15, price-to-book of 6.38, price-to-sales of 3.91. Over the past 52 weeks the stock has ranged between $0.69 and $3.96, and currently trades 36.9% below its 52-week high.

On profitability, 3-D Matrix, Ltd. generates a return on equity (ROE) of 89.26% — well above the market average, a sign of a high-quality business, return on capital employed of 19.52%, an operating margin of 12.27%, a net profit margin of 38.17%.

Official website: www.3d-matrix.co.jp

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides